Supplementary Files
Keywords
Antimicrobial activity
Phytochemical
Venezuela
Valeriana
actividad antimicrobiana
fitoquímica
Venezuela.
How to Cite
Abstract
Valeriana L. genus is represented in Venezuela by 16 species, 9 of these are endemic of Venezuelan Andes growing in high mountains at 2800 masl. In this investigation, four species were analyzed in order to determine the main secondary metabolites and antimicrobial activity of extracts obtained from aerial parts of Valeriana parviflora, V. rosaliana, V. triplinervis and V. phylicoides. Alkaloids, flavonoids, tannins, sterols, triterpenoids and saponins were qualitatively observed in all methanolic extracts tested. The color intensity or a precipitate formation was used as analytical response to these tests. Antimicrobial activity was evaluated against Gram positive, Gram negative bacterial strains and yeast, using disc diffusion method. N-hexane extracts of V. triplinervis and V. rosaliana showed the highest efficiency against Staphylococcus aureus, exhibiting inhibition zones of 16 mm and 15 mm; MIC (Minimal Inhibition Concentration) values were observed at 116 mg/mL and 150 mg/mL, respectively. Dichloromethane and methanolic extracts of V. triplinervis and methanolic extract of V. rosaliana showed a rather moderate activity (MIC between 200 to 316 mg/ml) but a very weak antibacterial activity was observed in V. phylicoides and V. parviflora extracts (MIC > 420 mg/mL). None of the extracts assayed in this investigation showed any activity against Candida albicans and Candida krusei. Statistical analysis showed no significant differences on the different polarity extracts assayed with respect to antimicrobial activity against S. aureus (P > 0.10), however it was observed significant differences between the Valeriana species analyzed (P < 0.10) in relation to the minimal inhibitory concentration (MIC).
References
Aydin, F., Dikmen, B., & Kismali, G. (2016). The potential cytotoxic effects of Valeriana officinalis extracto on protate cáncer cell line DU-145 and PC-3. Toxicology Letters, 258, S299.
Backlun, A., & Moritz, T. (1998). Phylogenetic implications of an expanded valepotriate distribution in the Valerianaceae. Biochemical Systematic and Ecology, 26, 309-335.
Bell, C., & Dologhue, M. (2005). Phylogeny and biogeography of Valerianaceae (Dipsacales) with special reference to the South America valerians. Organims, Diversity & Evolution, 5, 137-149.
Bhatt, I., Dauthal, P., Rawat, S., Gaira, K., Jugran, A., Rawal, R., & Dhar, U. (2012). Characterization of essential oil composition, phenolic content, and antioxidant properties in wild and planted individuals of Valeriana jatamansi Jones. Scientia Horticulturae, 136, 61-68.
Blomfeldt, A., Eskesen, A., Aamot, H., Leegaard, T., & BiØrnholt, J. (2016) Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality. European Journal Clinical Microbiology & Infectious Diseases, 35, 803-13.
Celis, C., Rincón, J., & Guerrero M. (2007). Actividad farmacológica sobre el Sistema Nervioso Central del extracto etanólico y fracción alcaloidal de Valeriana pavonii. Revista Colombiana de Ciencias Químicas y Farmacéuticas, 36, 11-22.
Chen, H. W., He, X. H., Yuan, R., Wei, B. J., Chen, Z., Dong, J. X., & Wang, J. (2016). Sesquiterpenes and monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo. Fitoterapia, 110, 142-149.
Fernández, S., Rondón, M., Rojas, J., Morales, A., & Rojas-Fermín, L. (2015). Comparison of the Chemical Composition of Valeriana parviflora Essential Oils Collected in the Venezuelan Andes in two Different Seasons. Natural Product Communication, 10, 657-659.
Fernández, S., Wasowski, C., Paladini, A., & Marde, M. (2004). Sedative and sleep.enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. Pharmacology Biochemistry and Behavior, 77, 399-404.
Gilani, A., Khan, A. U., Jabeen, Q., Subhan, F., & Ghafar, R. (2005). Antispasmodic and blood pressure lowering effects of Valeriana wallichii mediated through K+ channel activation. Journal of Ethnopharmacology, 100, 347-352.
Harborne, J. B. (1973). Phytochemical methods, A Guide to Modern Techniques of plant analysis, Chapman and Hall, London, Ltd, 49-188.
Houghton, P. (1988). The biological activity of Valerian and related plant. Journal of Ethonopharmacology, 22, 121-142.
Houghton, P. (1998). The scientific basis for the reputed activity of Valerian. Journal of Pharmacy and Pharmacology, 51, 505-512.
Jiang, X., Zhang, J. C., Liu, Y. W., & Fang, Y. (2007). Studies on chemical constituents of Valeriana officinalis (in Chinese). Zhong Yao Cai, 30, 1391-1393.
Marder, M., Viola, H., Wasowski, C., Fernández, S., Medina, J., Paladini, A. (2003). 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacology Biochemitry and Behavior, 75, 537-545.
Miyasaka, L., & Soares, B. (2006). Valerian for anxiety disorders. Cochrane Database of Systematic Reviews 18, CD004515. DOI: 10.1002/14651858.CD004515.pub2
Nadinic, E., Penna, C., Saavedra, C., Coussio, J., Gutkind, G., & Debenedetti, S. (2002). Aislamiento de los Compuestos con Actividad Antimicrobiana de Extractos de Gentianella achalensis (Gilg) Ho & Liu (Gentianaceae). Acta Farmacéutica Bonaerenses, 21, 123-130.
National Committee for Clinical Laboratory Standards (NCCLS). (2004). Performance standards for antimicrobial disk sus-ceptibility testing. Fourteenth informational supplement. Wayne, Pa: NCCLS document M100-S14.
Patoĉka, J., & Jakl, J. (2010). Biomedically relevant chemical constituents of Valeriana officinalis. Journal of Applied Biomedicine, 8, 11-18.
Potdar, V. H., Lole, V. D., & Patil, S. S. (2011). In-vitro Anthelmintic Activity of Rhizomes of Valeriana wallichii DC (Valerianaceae) Against Pheretima posthuma. Indial. Journal of Pharmaceutical Education and Research, 45, 83-85.
Sati, S. C., Khulbe, K., & Joshi, S. (2011). Antibacterial Evaluation of the Himalayan Medicinal Plant Valeriana wallichii DC. (Valerianaceae). Research Journal of Microbiology, 6, 289-296.
Sridharan, S., Mohankumar, K., Kumar, S., Sankaramourthy, D., Ronsard, L., Subramanian, K., … Sadras, S. (2015). Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice. Neuro Toxicology, 51, 172-183.
Tan, Y. Z., Yong, Y., Dong, Y. H., Wang, R. J., Li, H. X., Zhang, H., … Xie, X. F. (2016). A new secoiridoid glycoside and a new sesquiterpenoid glycoside from Valeriana jatamansi with neuroprotective activity. Phytochemistry Letters, 17, 177-180.
Tong, S., Davis, J., Eichenberger, E., Holland, T., & Fowler, V. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Review, 28, 603-661.
Tzakou, O., Couladis, M., Pavlovic, M., & Sokovic, M. (2004). Composition and antifungical activity of the oil from aerial parts rizhomes of Valeriana dioscoridis from Greece. Journal of Essential Oil Research, 16, 500-503.
Velasco, J., Rojas, J., Salazar, P., Rodríguez, M., Díaz, T., Morales, A., & Rondón, M. (2007). Antibacterial activity of the essential oil of Lippia oreganoides against multiresistant bacterial strains of nosocomial origin. Natural Product Communication, 2, 85-88.
Wang, J., Zhao, J., Liu, H., Zhou, L., Liu, Z., Wang, … Yang, F. (2010). Chemical Analysis and Biological Activity of the Essential Oils of Two Valerianaceous Species from China: Nardostachys chinensis and Valeriana officinalis. Molecules, 15, 6411-6422.
Xena, E. N. (1993). Contribución al estudio del género Valeriana L. en Venezuela: Distribución geográfica, caracteres morfoanatómicos, cariológicos y palinológicos de interés taxonómico y evolutivo. Acta Botánica Venezuelica, 16, 105-115.
Zhou, Y., Fang, Y., Gong, Z., Duan, X., & Liu Y. (2009). Two news terpenoids from Valeriana officinalis. Chinese Journal of Natural Medicine, 7, 270-273.
Comments
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2018 Revista de Biología Tropical